Skip to content
Brits Take Point

Zimbabwe Rejects ‘Lopsided’ US Healthcare Assistance Deal Due to Data Apprehensions

Health funding image
The offered US financial assistance would have supported programmes for treating and preventing HIV/Aids, tuberculosis, and malaria.

The nation of Zimbabwe has turned down a major US health deal worth 367 million US dollars (£272m) spanning five years over the United States' demand for confidential data.

This move was revealed after a official document dated December was disclosed, indicating that President Emmerson Mnangagwa deemed the arrangement was "unbalanced".

An official spokesperson later explained that the United States was seeking genetic material for scientific study and commercial purposes while was unwilling to guarantee the resulting advantages from any future vaccines.

"We are forced to start the challenging and unfortunate process of ending our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy noted the US had donated more than $1.9bn as health assistance to Zimbabwe over the last two decades.

A physicians' group in Zimbabwe has appealed for further talks to reach a agreement acceptable to both sides so the country's vital HIV programme can proceed.

Broader Background

This rejection follows a comparable situation in Kenya, where a court suspended a similar health funding agreement following concerns were raised about the security of Kenyans' medical information.

Since resuming office last year, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.

The agency had managed assistance for the US government, but Trump claimed its spending was "inefficient" and his administration was pursuing government-to-government deals to boost transparency and accountability.

Based on statements, 16 African countries have so far agreed to these new health pacts, representing over $18.3bn in committed funds.

Specifics of the Declined Agreement

The money for Zimbabwe would have funded "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"We believe this collaboration could have provided immense advantages for the people of Zimbabwe, especially the 1.2 million presently on HIV treatment through American-funded programmes," Tremont commented.

However, official spokesman Nick Mangwana argued the proposed deal was "asymmetrical".

"The proposal required Zimbabwe to surrender its biological resources and data for a long time, with no corresponding guarantee of access to any scientific breakthroughs – such as new medicines or tests – that could be developed from that shared data," he stated.

"Put simply, our country would supply the raw materials for medical research with no assurance that the final treatments would be available to our population should a new pandemic arise."

National Interest and Global Health

He also noted that the US's withdrawal from the global health body and its push of bilateral health agreements were upending frameworks already set up through the international organization.

Mangwana cited its Pathogen Access and Benefit Sharing framework designed to deal with potential global health emergencies.

"This system is intended to guarantee that when a country contributes its data, the resulting advantages – such as medicines and cures – are shared equitably, not monopolised solely by those with the funds to create them."

These objections over the US deal "are not meant as anti-American sentiment," he added.

"We encourage ongoing discussions with our American counterparts on how future co-operation might be arranged in a way that respects the independence and dignity of each country."

Medical Community Reaction

A leading public health body said it understood the official position, but suggested that talks must proceed since much of the country's Aids initiatives relied on external financing.

"Where technical issues exist, such as those relating to information security or implementation frameworks, these can often be resolved via technical clarification and mutually agreed protections," the group added.

The halted deal underscores the continuing challenges between accepting much-needed foreign assistance and safeguarding a country's data in an ever more interconnected world.

About the author

Stefanie Martin

Eleanor Hartwell is a British journalist with a decade of experience covering politics, social issues, and cultural trends from London.

Brits Take Point

Type to search articles.